other material
confidence high
sentiment neutral
materiality 0.70
Skye Bioscience increases authorized common shares from 20M to 100M and expands equity incentive pool
Skye Bioscience, Inc.
- Board and majority stockholders approved incentive plan amendment raising authorized shares to 1,846,883, with automatic 5% annual increases from 2024-2032.
- Charter amendment increases authorized common stock from 20,000,000 to 100,000,000 shares, approved by majority stockholders via written consent on Sept 29, 2023.
- Both actions become effective 20 calendar days after mailing of definitive information statement to stockholders.
- Incentive plan amendment allows grants of stock options, SARs, restricted stock, RSUs, and performance awards.
- Majority stockholders executed written consents on Sept 29, 2023, bypassing stockholder meeting for both amendments.